↓ Cooling
Health
Big Pharma’s race to stop Alzheimer’s before it starts
Pharmaceutical companies and researchers are advancing diagnostic tools and preventative strategies in Alzheimer's disease.
Big Pharma
6 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Treasury sweeps biotech into proposed COINS Act restrictions, but spares Big Pharma’s China licensing deals
The US Treasury is proposing the COINS Act to restrict high-tech investments in China, specifically targeting the biotech sector while exempting certain deals.
◼ Archived
Business
4 red flags – and 1 truth
Unregulated peptide hype meets alarming health reports and a puzzling pharma link, prompting a four‑flag warning list.
◼ Archived
Business
🔮 fades ✓
‘Unlikely’ AstraZeneca-BMS mega-merger would be largest pharma deal ever
Analysts express perplexity as reports indicate active merger talks between Bristol-Myers Squibb and AstraZeneca.
◼ Archived
Health
🔮 fades ✗
Ozempic is changing workplace etiquette
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
Eli Lilly's $3.8 billion acquisition of AtaiBeckley signals a major shift as Big Pharma begins to validate the psychedelic medicine sector.